(en) London B, Michalec M, Mehdi H, Zhu X, Dudley Jr SC et al., « Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na+ current and causes inherited arrhythmias », Circulation, vol. 116, no 20, , p. 2260–8. (PMID17967977, PMCIDPMC3150966, DOI10.1161/CIRCULATIONAHA.107.703330, résumé)
(en) Lambiase PD, Ahmed AK, Ciaccio EJ et al., « High-density substrate mapping in Brugada syndrome: combined role of conduction and repolarization heterogeneities in arrhythmogenesis », Circulation, vol. 120, no 2, , p. 106-17, 1-4. (PMID19564561, DOI10.1161/CIRCULATIONAHA.108.771401, résumé)
(en) Coronel R, Casini S, Koopmann TT, Wilms-Schopman FJG, de Bakker JMT et al., « Right ventricular fibrosis and conduction delay in a patient with clinical signs of Brugada syndrome: a combined electrophysiological, genetic, histopathologic and computational study », Circulation, vol. 112, no 18, , p. 2269–77. (PMID16267250, DOI10.1161/CIRCULATIONAHA.105.532614, lire en ligne)
(en) Brugada R, Brugada J, Antzelevitch C et al., « Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts », Circulation, vol. 101, no 5, , p. 510–5. (PMID10662748, DOI10.1161/01.cir.101.5.510, lire en ligne [html])
(en) Probst V, Veltmann C, Eckardt L, Meregalli PG, Wilde AAM et al., « Long-term prognosis of patients diagnosed with Brugada syndrome: results from the Finger Brugada Syndrome Registry », Circulation, vol. 121, no 5, , p. 635-43. (PMID20100972, DOI10.1161/CIRCULATIONAHA.109.887026, résumé)
(en) Sarkozy A, Chierchia GB, Paparella G et al., « Inferior and lateral electrocardiographic repolarization abnormalities in Brugada syndrome », Circ Arrhythm Electrophysiol, vol. 2, no 2, , p. 154–61. (PMID19808460, DOI10.1161/CIRCEP.108.795153, lire en ligne)
(en) Pappone C, Brugada J, Vicedomini G, Ciconte G, Santinelli V et al., « Electrical substrate elimination in 135 consecutive patients with Brugada syndrome », Circ Arrhythm Electrophysiol, vol. 10, no 5, , e005053. (PMID28500178, DOI10.1161/CIRCEP.117.005053, lire en ligne [html])
circgenetics.ahajournals.org
(en) Probst V, Wilde AAM, Barc J, Sacher F, Schott J-J et al., « SCN5A mutations and the role of genetic background in the pathophysiology of Brugada syndrome », Circ Cardiovasc Genet, vol. 2, no 6, , p. 552–7. (PMID20031634, DOI10.1161/CIRCGENETICS.109.853374, lire en ligne [html])
(en) Brugada P, Brugada J, « Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report », J Am Coll Cardiol, vol. 20, no 6, , p. 1391-6. (PMID1309182, DOI10.1016/0735-1097(92)90253-j, résumé)
(en) Chen Q, Kirsch GE, Zhang D, Brugada R, Wang Q et al., « Genetic basis and molecular mechanism for idiopathic ventricular fibrillation », Nature, vol. 392, no 6673, , p. 293–6. (PMID9521325, DOI10.1038/32675, résumé)
(en) Kapplinger JD, Tester DJ, Alders M, Benito B, Ackerman MJ et al., « An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing », Heart Rhythm, vol. 7, no 1, , p. 33–46. (PMID20129283, PMCIDPMC2822446, DOI10.1016/j.hrthm.2009.09.069, lire en ligne [html])
(en) Bezzina CR, Barc J, Mizusawa Y, Remme CA, Gourraud JB, Redon R et al., « Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death », Nat Genet, vol. 45, no 9, , p. 1044–9. (PMID23872634, PMCIDPMC3869788, DOI10.1038/ng.2712, lire en ligne [html])
(en) London B, Michalec M, Mehdi H, Zhu X, Dudley Jr SC et al., « Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na+ current and causes inherited arrhythmias », Circulation, vol. 116, no 20, , p. 2260–8. (PMID17967977, PMCIDPMC3150966, DOI10.1161/CIRCULATIONAHA.107.703330, résumé)
(en) Novelli V, Memmi M, Malovini A, Mazzanti A, Priori SG et al., « Role of CACNA1C variants in Brugada syndrome: clinical aspects and genetic testing strategies », Eur Heart J, vol. 41, no Supplement_2, , ehaa946.3584 (DOI10.1093/ehjci/ehaa946.3584, lire en ligne [html])
(en) Probst V, Wilde AAM, Barc J, Sacher F, Schott J-J et al., « SCN5A mutations and the role of genetic background in the pathophysiology of Brugada syndrome », Circ Cardiovasc Genet, vol. 2, no 6, , p. 552–7. (PMID20031634, DOI10.1161/CIRCGENETICS.109.853374, lire en ligne [html])
(en) Brugada J, Campuzano O, Arbelo E, Sarquella-Brugada G, Brugada R, « Present status of Brugada syndrome: JACC state-of-the-art review », J Am Coll Cardiol, vol. 72, no 9, , p. 1046-59. (PMID30139433, DOI10.1016/j.jacc.2018.06.037)
(en) Lambiase PD, Ahmed AK, Ciaccio EJ et al., « High-density substrate mapping in Brugada syndrome: combined role of conduction and repolarization heterogeneities in arrhythmogenesis », Circulation, vol. 120, no 2, , p. 106-17, 1-4. (PMID19564561, DOI10.1161/CIRCULATIONAHA.108.771401, résumé)
(en) Coronel R, Casini S, Koopmann TT, Wilms-Schopman FJG, de Bakker JMT et al., « Right ventricular fibrosis and conduction delay in a patient with clinical signs of Brugada syndrome: a combined electrophysiological, genetic, histopathologic and computational study », Circulation, vol. 112, no 18, , p. 2269–77. (PMID16267250, DOI10.1161/CIRCULATIONAHA.105.532614, lire en ligne)
(en) Pieroni M, Notarstefano P, Oliva A et al., « Electroanatomic and pathologic right ventricular outflow tract abnormalities in patients with Brugada syndrome », J Am Coll Cardiol, vol. 72, no 22, , p. 2747-57. (PMID30497561, DOI10.1016/j.jacc.2018.09.037, lire en ligne [html])
(en) Nademanee K, Raju H, de Noronha SV, Papadakis M, Behr ER et al., « Fibrosis, connexin-43, and conduction abnormalities in the Brugada syndrome », J Am Coll Cardiol, vol. 66, no 18, , p. 1976-86. (PMID26516000, PMCIDPMC4631798, DOI10.1016/j.jacc.2015.08.862, lire en ligne [html])
(en) Benito B, Sarkozy A, Mont L, Henkens S, Brugada J et al., « Gender Differences in Clinical Manifestations of Brugada Syndrome », J Am Coll Cardiol, vol. 52, no 19, , p. 1567-73. (PMID19007594, DOI10.1016/j.jacc.2008.07.052, résumé)
(en) Brugada R, Brugada J, Antzelevitch C et al., « Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts », Circulation, vol. 101, no 5, , p. 510–5. (PMID10662748, DOI10.1161/01.cir.101.5.510, lire en ligne [html])
(en) Richter S, Sarkozy A, Veltmann C, Chierchia G-B, Brugada P et al., « Variability of the diagnostic ECG pattern in an ICD patient population with Brugada syndrome », J Cardiovasc Electrophysiol, vol. 20, no 1, , p. 69–75. (PMID18775043, DOI10.1111/j.1540-8167.2008.01282.x, résumé)
(en) Makimoto H, Nakagawa E, Takaki H, Yamada Y, Shimizu W et al., « Augmented ST-segment elevation during recovery from exercise predicts cardiac events in patients with Brugada syndrome », J Am Coll Cardiol, vol. 56, no 19, , p. 1576–84. (PMID21029874, DOI10.1016/j.jacc.2010.06.033, résumé)
(en) Shimizu W, Matsuo K, Takagi M et al., « Body surface distribution and response to drugs of ST segment elevation in Brugada syndrome: clinical implication of eighty-seven-lead body surface potential mapping and its application to twelve-lead electrocardiograms », J Cardiovasc Electrophysiol, vol. 11, no 4, , p. 396–404. (PMID10809492, DOI10.1111/j.1540-8167.2000.tb00334.x, résumé)
(en) Sarkozy A, Chierchia GB, Paparella G et al., « Inferior and lateral electrocardiographic repolarization abnormalities in Brugada syndrome », Circ Arrhythm Electrophysiol, vol. 2, no 2, , p. 154–61. (PMID19808460, DOI10.1161/CIRCEP.108.795153, lire en ligne)
(en) Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Wilde A et al., « Brugada syndrome: report of the second consensus conference », Heart Rhythm, vol. 2, no 4, , p. 429–40. (PMID15898165, DOI10.1016/j.hrthm.2005.01.005)
(en) SG Priori, AA Wilde, M Horie, Cho Y, Tracy C et al., « HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013 », Heart Rhythm, vol. 10, no 12, , p. 1932-63. (PMID24011539, DOI10.1016/j.hrthm.2013.05.014, lire en ligne [html])
(en) Brugada P, Brugada R, Mont L, Rivero M, Brugada J et al., « Natural history of Brugada syndrome: the prognostic value of programmed electrical stimulation of the heart », J Cardiovasc Electrophysiol, vol. 14, no 5, , p. 455–57. (PMID12776858, DOI10.1046/j.1540-8167.2003.02517.x, résumé)
(en) Probst V, Veltmann C, Eckardt L, Meregalli PG, Wilde AAM et al., « Long-term prognosis of patients diagnosed with Brugada syndrome: results from the Finger Brugada Syndrome Registry », Circulation, vol. 121, no 5, , p. 635-43. (PMID20100972, DOI10.1161/CIRCULATIONAHA.109.887026, résumé)
(en) Viskin S, Wilde AAM, Tan HL, Antzelevitch C, Belhassen B et al., « Empiric quinidine therapy for asymptomatic Brugada syndrome: time for a prospective registry », Heart Rhythm, vol. 6, no 3, , p. 401–4. (PMID19251219, PMCIDPMC3005559, DOI10.1016/j.hrthm.2008.11.030, lire en ligne [html])
(en) Pappone C, Brugada J, Vicedomini G, Ciconte G, Santinelli V et al., « Electrical substrate elimination in 135 consecutive patients with Brugada syndrome », Circ Arrhythm Electrophysiol, vol. 10, no 5, , e005053. (PMID28500178, DOI10.1161/CIRCEP.117.005053, lire en ligne [html])
(en) Viskin S, Wilde AAM, Tan HL, Antzelevitch C, Belhassen B et al., « Empiric quinidine therapy for asymptomatic Brugada syndrome: time for a prospective registry », Heart Rhythm, vol. 6, no 3, , p. 401–4. (PMID19251219, PMCIDPMC3005559, DOI10.1016/j.hrthm.2008.11.030, lire en ligne [html])
(en) Chen Q, Kirsch GE, Zhang D, Brugada R, Wang Q et al., « Genetic basis and molecular mechanism for idiopathic ventricular fibrillation », Nature, vol. 392, no 6673, , p. 293–6. (PMID9521325, DOI10.1038/32675, résumé)
(en) Bezzina CR, Barc J, Mizusawa Y, Remme CA, Gourraud JB, Redon R et al., « Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death », Nat Genet, vol. 45, no 9, , p. 1044–9. (PMID23872634, PMCIDPMC3869788, DOI10.1038/ng.2712, lire en ligne [html])
nih.gov
ncbi.nlm.nih.gov
(en) Brugada P, Brugada J, « Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report », J Am Coll Cardiol, vol. 20, no 6, , p. 1391-6. (PMID1309182, DOI10.1016/0735-1097(92)90253-j, résumé)
(en) Chen Q, Kirsch GE, Zhang D, Brugada R, Wang Q et al., « Genetic basis and molecular mechanism for idiopathic ventricular fibrillation », Nature, vol. 392, no 6673, , p. 293–6. (PMID9521325, DOI10.1038/32675, résumé)
(en) Kapplinger JD, Tester DJ, Alders M, Benito B, Ackerman MJ et al., « An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing », Heart Rhythm, vol. 7, no 1, , p. 33–46. (PMID20129283, PMCIDPMC2822446, DOI10.1016/j.hrthm.2009.09.069, lire en ligne [html])
(en) Bezzina CR, Barc J, Mizusawa Y, Remme CA, Gourraud JB, Redon R et al., « Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death », Nat Genet, vol. 45, no 9, , p. 1044–9. (PMID23872634, PMCIDPMC3869788, DOI10.1038/ng.2712, lire en ligne [html])
(en) London B, Michalec M, Mehdi H, Zhu X, Dudley Jr SC et al., « Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na+ current and causes inherited arrhythmias », Circulation, vol. 116, no 20, , p. 2260–8. (PMID17967977, PMCIDPMC3150966, DOI10.1161/CIRCULATIONAHA.107.703330, résumé)
(en) Probst V, Wilde AAM, Barc J, Sacher F, Schott J-J et al., « SCN5A mutations and the role of genetic background in the pathophysiology of Brugada syndrome », Circ Cardiovasc Genet, vol. 2, no 6, , p. 552–7. (PMID20031634, DOI10.1161/CIRCGENETICS.109.853374, lire en ligne [html])
(en) Brugada J, Campuzano O, Arbelo E, Sarquella-Brugada G, Brugada R, « Present status of Brugada syndrome: JACC state-of-the-art review », J Am Coll Cardiol, vol. 72, no 9, , p. 1046-59. (PMID30139433, DOI10.1016/j.jacc.2018.06.037)
(en) Lambiase PD, Ahmed AK, Ciaccio EJ et al., « High-density substrate mapping in Brugada syndrome: combined role of conduction and repolarization heterogeneities in arrhythmogenesis », Circulation, vol. 120, no 2, , p. 106-17, 1-4. (PMID19564561, DOI10.1161/CIRCULATIONAHA.108.771401, résumé)
(en) Coronel R, Casini S, Koopmann TT, Wilms-Schopman FJG, de Bakker JMT et al., « Right ventricular fibrosis and conduction delay in a patient with clinical signs of Brugada syndrome: a combined electrophysiological, genetic, histopathologic and computational study », Circulation, vol. 112, no 18, , p. 2269–77. (PMID16267250, DOI10.1161/CIRCULATIONAHA.105.532614, lire en ligne)
(en) Pieroni M, Notarstefano P, Oliva A et al., « Electroanatomic and pathologic right ventricular outflow tract abnormalities in patients with Brugada syndrome », J Am Coll Cardiol, vol. 72, no 22, , p. 2747-57. (PMID30497561, DOI10.1016/j.jacc.2018.09.037, lire en ligne [html])
(en) Nademanee K, Raju H, de Noronha SV, Papadakis M, Behr ER et al., « Fibrosis, connexin-43, and conduction abnormalities in the Brugada syndrome », J Am Coll Cardiol, vol. 66, no 18, , p. 1976-86. (PMID26516000, PMCIDPMC4631798, DOI10.1016/j.jacc.2015.08.862, lire en ligne [html])
(en) Benito B, Sarkozy A, Mont L, Henkens S, Brugada J et al., « Gender Differences in Clinical Manifestations of Brugada Syndrome », J Am Coll Cardiol, vol. 52, no 19, , p. 1567-73. (PMID19007594, DOI10.1016/j.jacc.2008.07.052, résumé)
(en) Brugada R, Brugada J, Antzelevitch C et al., « Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts », Circulation, vol. 101, no 5, , p. 510–5. (PMID10662748, DOI10.1161/01.cir.101.5.510, lire en ligne [html])
(en) Richter S, Sarkozy A, Veltmann C, Chierchia G-B, Brugada P et al., « Variability of the diagnostic ECG pattern in an ICD patient population with Brugada syndrome », J Cardiovasc Electrophysiol, vol. 20, no 1, , p. 69–75. (PMID18775043, DOI10.1111/j.1540-8167.2008.01282.x, résumé)
(en) Makimoto H, Nakagawa E, Takaki H, Yamada Y, Shimizu W et al., « Augmented ST-segment elevation during recovery from exercise predicts cardiac events in patients with Brugada syndrome », J Am Coll Cardiol, vol. 56, no 19, , p. 1576–84. (PMID21029874, DOI10.1016/j.jacc.2010.06.033, résumé)
(en) Shimizu W, Matsuo K, Takagi M et al., « Body surface distribution and response to drugs of ST segment elevation in Brugada syndrome: clinical implication of eighty-seven-lead body surface potential mapping and its application to twelve-lead electrocardiograms », J Cardiovasc Electrophysiol, vol. 11, no 4, , p. 396–404. (PMID10809492, DOI10.1111/j.1540-8167.2000.tb00334.x, résumé)
(en) Sarkozy A, Chierchia GB, Paparella G et al., « Inferior and lateral electrocardiographic repolarization abnormalities in Brugada syndrome », Circ Arrhythm Electrophysiol, vol. 2, no 2, , p. 154–61. (PMID19808460, DOI10.1161/CIRCEP.108.795153, lire en ligne)
(en) Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Wilde A et al., « Brugada syndrome: report of the second consensus conference », Heart Rhythm, vol. 2, no 4, , p. 429–40. (PMID15898165, DOI10.1016/j.hrthm.2005.01.005)
(en) SG Priori, AA Wilde, M Horie, Cho Y, Tracy C et al., « HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013 », Heart Rhythm, vol. 10, no 12, , p. 1932-63. (PMID24011539, DOI10.1016/j.hrthm.2013.05.014, lire en ligne [html])
(en) Brugada P, Brugada R, Mont L, Rivero M, Brugada J et al., « Natural history of Brugada syndrome: the prognostic value of programmed electrical stimulation of the heart », J Cardiovasc Electrophysiol, vol. 14, no 5, , p. 455–57. (PMID12776858, DOI10.1046/j.1540-8167.2003.02517.x, résumé)
(en) Probst V, Veltmann C, Eckardt L, Meregalli PG, Wilde AAM et al., « Long-term prognosis of patients diagnosed with Brugada syndrome: results from the Finger Brugada Syndrome Registry », Circulation, vol. 121, no 5, , p. 635-43. (PMID20100972, DOI10.1161/CIRCULATIONAHA.109.887026, résumé)
(en) Viskin S, Wilde AAM, Tan HL, Antzelevitch C, Belhassen B et al., « Empiric quinidine therapy for asymptomatic Brugada syndrome: time for a prospective registry », Heart Rhythm, vol. 6, no 3, , p. 401–4. (PMID19251219, PMCIDPMC3005559, DOI10.1016/j.hrthm.2008.11.030, lire en ligne [html])
(en) Pappone C, Brugada J, Vicedomini G, Ciconte G, Santinelli V et al., « Electrical substrate elimination in 135 consecutive patients with Brugada syndrome », Circ Arrhythm Electrophysiol, vol. 10, no 5, , e005053. (PMID28500178, DOI10.1161/CIRCEP.117.005053, lire en ligne [html])
(en) Brugada P, Brugada J, « Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report », J Am Coll Cardiol, vol. 20, no 6, , p. 1391-6. (PMID1309182, DOI10.1016/0735-1097(92)90253-j, résumé)
(en) Nademanee K, Raju H, de Noronha SV, Papadakis M, Behr ER et al., « Fibrosis, connexin-43, and conduction abnormalities in the Brugada syndrome », J Am Coll Cardiol, vol. 66, no 18, , p. 1976-86. (PMID26516000, PMCIDPMC4631798, DOI10.1016/j.jacc.2015.08.862, lire en ligne [html])
(en) Benito B, Sarkozy A, Mont L, Henkens S, Brugada J et al., « Gender Differences in Clinical Manifestations of Brugada Syndrome », J Am Coll Cardiol, vol. 52, no 19, , p. 1567-73. (PMID19007594, DOI10.1016/j.jacc.2008.07.052, résumé)
(en) Makimoto H, Nakagawa E, Takaki H, Yamada Y, Shimizu W et al., « Augmented ST-segment elevation during recovery from exercise predicts cardiac events in patients with Brugada syndrome », J Am Coll Cardiol, vol. 56, no 19, , p. 1576–84. (PMID21029874, DOI10.1016/j.jacc.2010.06.033, résumé)
oup.com
academic.oup.com
(en) Novelli V, Memmi M, Malovini A, Mazzanti A, Priori SG et al., « Role of CACNA1C variants in Brugada syndrome: clinical aspects and genetic testing strategies », Eur Heart J, vol. 41, no Supplement_2, , ehaa946.3584 (DOI10.1093/ehjci/ehaa946.3584, lire en ligne [html])
(en) Kapplinger JD, Tester DJ, Alders M, Benito B, Ackerman MJ et al., « An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing », Heart Rhythm, vol. 7, no 1, , p. 33–46. (PMID20129283, PMCIDPMC2822446, DOI10.1016/j.hrthm.2009.09.069, lire en ligne [html])
(en) Pieroni M, Notarstefano P, Oliva A et al., « Electroanatomic and pathologic right ventricular outflow tract abnormalities in patients with Brugada syndrome », J Am Coll Cardiol, vol. 72, no 22, , p. 2747-57. (PMID30497561, DOI10.1016/j.jacc.2018.09.037, lire en ligne [html])
(en) SG Priori, AA Wilde, M Horie, Cho Y, Tracy C et al., « HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013 », Heart Rhythm, vol. 10, no 12, , p. 1932-63. (PMID24011539, DOI10.1016/j.hrthm.2013.05.014, lire en ligne [html])
wiley.com
onlinelibrary.wiley.com
(en) Richter S, Sarkozy A, Veltmann C, Chierchia G-B, Brugada P et al., « Variability of the diagnostic ECG pattern in an ICD patient population with Brugada syndrome », J Cardiovasc Electrophysiol, vol. 20, no 1, , p. 69–75. (PMID18775043, DOI10.1111/j.1540-8167.2008.01282.x, résumé)
(en) Shimizu W, Matsuo K, Takagi M et al., « Body surface distribution and response to drugs of ST segment elevation in Brugada syndrome: clinical implication of eighty-seven-lead body surface potential mapping and its application to twelve-lead electrocardiograms », J Cardiovasc Electrophysiol, vol. 11, no 4, , p. 396–404. (PMID10809492, DOI10.1111/j.1540-8167.2000.tb00334.x, résumé)
(en) Brugada P, Brugada R, Mont L, Rivero M, Brugada J et al., « Natural history of Brugada syndrome: the prognostic value of programmed electrical stimulation of the heart », J Cardiovasc Electrophysiol, vol. 14, no 5, , p. 455–57. (PMID12776858, DOI10.1046/j.1540-8167.2003.02517.x, résumé)